Award of Warrants to Director

RNS Number : 5446C
Asimilar Group PLC
20 October 2020
 

20 October 2020

Asimilar Group plc

("Asimilar" or the "Company")

Award of Warrants to Director

 

 

Asimilar Group plc (AIM: ASLR), the AIM quoted investment company focused on technology opportunities in the fields of big data, machine learning, telematics and the Internet of Things (IoT) , announces that the Company has issued warrants to subscribe for 1,000,000 new ordinary shares ("Warrants") to Mark Horrocks following his appointment to the Board as Non-Executive Director on 23 September 2020.  This represents 0.93% of the current issued share capital in the Company. The Warrants are exercisable at a price of 30 pence per share, and may be exercised, subject to the provisions of the Company's share dealing code, at any time within three years from issue.

 

As part of Mark Horrocks' Service Agreement, he has agreed to forego any salary entitlement in association with his employment as a Non-Executive Director of Asimilar Group Plc for 12 months from the date of his appointment.  The granting of the Warrants to Mark Horrocks is considered to be a related party transaction ("Transaction") pursuant to Rule 13 of the AIM Rules for Companies. The directors of the Company (excluding Mark Horrocks) consider, having consulted with the Company's nominated adviser, Cairn Financial Advisers LLP, that the terms of the Transaction are fair and reasonable insofar as its shareholders are concerned.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mark Horrocks

2

Reason for the notification

a)

Position/status

Non-executive Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Asimilar Group Plc

b)

LEI

213800AYJZ2B8QNY7H15

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Warrants to subscribe for Ordinary shares of 0.01 pence per share par value 

 

GB00BFX2VL54

b)

Nature of the transaction

Issue of Warrants

c)

Price(s) and volume(s)

Price(s)

Volume(s)

30.0p

1,000,000

 

 

 

d)

Aggregated information

-

Aggregated volume

-

Price

 

1,000,000 Warrants to subscribe for Ordinary shares of 0.01 pence per share par value

30.0 pence per Ordinary share

e)

Date of the transaction

19 October 2020

f)

Place of the transaction

Outside a trading venue

 

 

Mark Horrocks, his related parties and other members of his family have an interest in 5,422,947 Asimilar ordinary shares, representing 5.1% of Asimilar's issued share capital.  Mark Horrocks has additional warrants to subscribe for up to 9,000,000 Asimilar ordinary shares in 2 tranches of up to 4,500,000 warrants per tranche.  Each tranche will be exercisable for two years after the relevant price criteria having been reached.  The relevant price criteria are the mid-market closing price of shares in Dev Clever Holdings plc for a period of five consecutive Business Days being or exceeding (i) 28 pence; and (ii) 55 pence respectively.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

- ENDS - 

Contacts

Asimilar Group plc


John Taylor, Non-Executive Chairman

via Buchanan



Cairn Financial Advisers LLP


Sandy Jamieson / Liam Murray

Tel: +44 20 7213 0880



Peterhouse Capital Limited


Duncan Vasey / Lucy Williams

Tel: + 44 20 7220 9797



Buchanan Communications Limited


Richard Oldworth / Chris Lane

Tel: +44 (0) 20 7466 5000

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGPGBWUUPUPGB
UK 100